Pacgen Life Science Corporation (Pacgen) is a Canada-based life science technology company. The Company is focused on the commercialization of biomedical products and services. The Company has a license to develop and commercialize a novel antifungal called PAC-113. The Company's PAC-113 is a 12 amino-acid antimicrobial peptide. The Company, through General Biologicals Corporation (GBC), offers non-prescription over-the-counter (OTC) products containing PAC-113 in Taiwan, including cosmetic skin-care products, oral hygiene products and intimate hygiene products. The Company's PAC-113, which is an anti-fungal for the treatment of oral Candidiasis infections, completed a Phase IIb clinical program. Its products include Fit X1 Series, Electronic Pipettes and A+ Pipette Controller. Its Fit X1 401 is an automated pipetting system. Pacgen's A+ Pipette Controller is an electronic pipette controller for use with graduated and volumetric glass and plastic pipettes.